Dubutamine 1 (Ee09a55f 9992 48bb B8d6 1184bd548536 00)
Dobutamine Injection
Product Images NDC 70436-203
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dobutamine (NDC 70436-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Slate Run Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
70436-203-80 (Image 01)
This is a description of a Dobutamine injection, a medication used for intravenous use, which must be diluted prior to use. The medication comes in a single-dose vial of 20 mL (250 mg/20mL, 12.5 mg/mL) with NDC number 70436-203-80. Each mL of the medication comprises 12.5 dobutamine as the hydrochloride; sodium metabisulfite, 0.2 mg added. In addition, it may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. The medication is manufactured by Hainan Poly Pharm. Co., Ltd. and distributed by Slate Run Pharmaceuticals, LLC. The label provides precise instructions for dilution, dosage and administration, and precautions for storage.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
